|
Type of Company:
Type:
|
Company
|
Ownership: |
Privately Held |
Company Size: |
65 Employees In BC (65 Total)
65 In BC (65 Total)
|
Revenue: |
$11.75 Million CAD |
Year Founded: |
1992 |
Sector: |
Biotech/Life Sciences
Biotech/Life Sciences
|
Region: |
Lower Mainland / South Coast
Lower Mainland
|
Tags: |
diagnostic, testing, RAMP, disease, biotech
|
Profile Views: |
1,944 Company Profile Views |
|
|
Response Biomedical Corp. (TSX: RBM, OTCBB: RPBIF), based in Vancouver, Canada, was founded in 1992. Response develops, manufactures and markets rapid on-site diagnostic tests at its world class manufacturing facility in Vancouver, Canada, for use on the RAMP® Platform. The RAMP®Platform is sold worldwide and includes a variety of testing applications in the clinical, infectious disease, biodefense and environmental arenas. The RAMP® Platform provides laboratory quality results with the speed, precision and accuracy that many hospitals expect of their central lab systems. It is ideally suited for both point of care testing and laboratory use. The RAMP® Platform consists of a reader and single-use disposable test cartridges and has the potential to be adapted to more than 250 medical and non-medical tests currently performed in laboratories.
In 2012, Response acquired new leadership. Response proudly announced the appointment of Jeffrey L. Purvin as Director and Chief Executive Officer and W.J. (Bill) Adams as Chief Financial Officer and Corporate Secretary. Mr. Tim Shannon, Senior Vice President of Worldwide Sales and Marketing and Zheng (James) Wang, General Manager of the Regional Office in China, were also highly welcomed additions to the Senior Management team. The background and collective experience of all Senior Management team members has poised Response to drive worldwide marketing strategies that will enhance the company's growth moving forward. Product strategy initiatives aimed at emerging diagnostic needs will also be at the forefront of Response's focus.
Also in 2012, Response formed a newly created wholly owned subsidiary in the U.S. (Response Point of Care Inc.) and opened Regional Offices in Charlotte, N.C., U.S.A. and Shanghai, China to facilitate and enhance the truly global nature of Response. In addition to the Corporate Office in Vancouver, Canada, the regional offices will strengthen and support Response's extensive Global Distribution Network.
|
|
|
Date |
Type |
Amount |
Investors |
Date |
Type |
Amount |
Investors |
|
|
|
Dec 13, 2022
|
Response Biomedical's RAMP COVID-19 Antigen Test Gets Health Canada Approval
|
Nov 30, 2016
|
Response Biomedical Corp. Completes Going-Private Transaction
|
Nov 17, 2016
|
Response Biomedical Corp. Announces Third Quarter 2016 Financial Results and Update on Going-Private Transaction
|
Sep 19, 2016
|
Response Biomedical Receives Shareholder Approval of Going-Private Transaction
|
Aug 29, 2016
|
Response Biomedical Announces Q2 2016 Financial Results - Revenue Down Sharply, Losses Widen, Acquisition Pending
|
Jun 23, 2016
|
Response Biomedical Corp. Announces Closing of First Tranche of Private Placement
|
Jun 17, 2016
|
Response Biomedical Enters into Definitive Agreements for Going-Private Transaction (and $1.0 Million US Private Placement)
|
Apr 8, 2016
|
Response Biomedical Corp. Awarded Capital Equipment Supplier Contract by Vizient, Inc.
|
Feb 19, 2016
|
Response Biomedical Announces Launch of RAMP Dengue Test for Mosquitoes Carrying Zika Virus (among others)
|
Jan 4, 2016
|
Response Biomedical Corp. Announces Receipt of Fifth Milestone in Co-Development Collaboration
|
|
1 - 10 of 103 results
|
|
 |
|
|
|
Share This Company Profile |
|
Disclaimer: Company Profiles in the Tech Directory on T-Net are created, edited and maintained primarily by employees within individual companies, and are subject to continual change without notice and possible errors and/or omissions. Information within the pages of this Tech Directory is of a general nature intended only for informational purposes, and such information should not be relied upon. T-Net does not warrant or guarantee the quality, accuracy or completeness of such information and expressly disclaims liability for any loss, inconvenience or damages (including special, indirect or consequential damages) caused as a result of any errors in, or omissions from, such information. If you see an error, please let us know. Copyright T-Net. All rights reserved.
|
|